A new partnership will bring three new medications to the Middle East and North Africa, including an Ocrevus biosimilar drug ...

Progressive MS and High-Dose Biotin: Where Do We Stand? —Physicians from the Cleveland Clinic comment on studies, both positive and negative, on the use of biotin for the treatment of MS disability.

The SPRINT-MS trial evaluated the novel drug ibudilast over 96 weeks in patients with primary and secondary progressive multiple sclerosis. In a conversation at the 2019 American Academy of ...

Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 3 clinical study titled ‘A Randomized, ...

“Primary progressive MS is arguably one of the most severe and debilitating disease forms, but for many years, we have not had an effective way to research and ultimately treat it,” said Dr ...

Immunic receives US patent protecting vidofludimus calcium's dose strengths in progressive multiple sclerosis: New York Wednesday, September 10, 2025, 13:00 Hrs [IST] Immunic, Inc ...

Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in ...

Patients who developed secondary progressive MS at 20 years had more cortical lesions at baseline than patients with clinically isolated syndrome, relapsing-remitting MS, or primary progressive MS.

The role of imaging in diagnosing progressive multiple sclerosis and in assessing prognosis is the subject of a new review.

An early clinical trial looking at stem cell therapy for progressive multiple sclerosis suggests that it could halt the progression of motor disability and cognitive impairment.

After screening hundreds of generic drugs, researchers find that clomipramine targets three drivers of progressive multiple sclerosis in mice and cells.

Why MS patients develop progressive disability Date: July 19, 2021 Source: Mayo Clinic Summary: Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and ...